retinitis pigmentosa gene therapy (Eudora)

N/A

Report date: 2025/01/26 19:20:54

Base Information

Drug Nameretinitis pigmentosa gene therapy (Eudora)
Drug Alias NameHerpes virus based gene therapy (Eudora)HSV vector-delivered gene therapy (Eudora)HSV-1 based gene therapy (Eudora)
ClassificationBiologics
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesEudora Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesEudora Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A